Your browser doesn't support javascript.
loading
Alpha Particle Enhanced Blood Brain/Tumor Barrier Permeabilization in Glioblastomas Using Integrin Alpha-v Beta-3-Targeted Liposomes.
Sattiraju, Anirudh; Xiong, Xiaobing; Pandya, Darpan N; Wadas, Thaddeus J; Xuan, Ang; Sun, Yao; Jung, Youngkyoo; Sai, Kiran Kumar Solingapuram; Dorsey, Jay F; Li, King C; Mintz, Akiva.
Affiliation
  • Sattiraju A; Department of Radiology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Xiong X; Department of Radiology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Pandya DN; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Wadas TJ; Department of Radiology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Xuan A; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Sun Y; Department of Nuclear Medicine and Radiology, the People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Jung Y; Department of Radiology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Sai KKS; Department of Radiology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Dorsey JF; Department of Radiology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Li KC; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Mintz A; Department of Radiology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Mol Cancer Ther ; 16(10): 2191-2200, 2017 10.
Article in En | MEDLINE | ID: mdl-28619756

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Delivery Systems / Glioblastoma / Neovascularization, Pathologic Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2017 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Delivery Systems / Glioblastoma / Neovascularization, Pathologic Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2017 Type: Article